Arvinas (ARVN): Chief Scientific Officer sold ~$19K
Angela M Cacace, Chief Scientific Officer at Arvinas, sold ~$19K of Arvinas shares.
- ~$19K
- Approx. value · 2,583 sh @ $7.49
- 154K
- Holds after · shares reported
- Traded
- Jun 17, 2025
- Filed
- Jun 18, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jun 17, 2025 · this disclosureInsiderOfficer sold ~$19K of ARVN shares in the open market
What came next
- Jun 24, 2025InsiderCFO sold ~$43K of ARVN shares in the open market
- Sep 17, 2025Company filing · Form 8-K · Restructuring, Reg FDAnnounced job cuts, closures or a restructuring, and shared information with investors (and 1 more item)“On September 17, 2025, management of Arvinas, Inc. (the “Company’), pursuant to authority delegated by the Board of Directors of the Company (the “Board”), committed to and approved a reduction in workforce of approximately 15% across roles in functional areas of the Company primarily related to vepdegestrant commercialization.”
- Sep 22, 2025Insider · First insider buy since Dec 2020Director purchased ~$227K of ARVN shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Arvinas
For Arvinas, OQRO holds 1 insider filing (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ARVN page.
Other recent filings by Angela M Cacace, Chief Scientific Officer
The full history of Angela M Cacace, Chief Scientific Officer is on the profile page.
How this filing works
Explore the data
Other disclosures at Arvinas
- SEC Form 4Nov 9, 2026
- SEC Form 4Sep 24, 2025
- SEC Form 13F-HRAug 14, 2025
- SEC Form 13F-HRAug 6, 2025
- SEC Form 4Jun 24, 2025
- SEC Form 13F-HRMay 14, 2025
Everything OQRO holds on this company is on its ARVN page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data